Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Elu
暂无分享,去创建一个
K. Anstrom | M. Leon | L. Mauri | D. Kandzari | E. Eisenstein | P. Cowper | D. Kong | R. Edwards